Stockscreener 앱 받기
97.06
0.38%
-0.37
시간 외 거래:
97.00
-0.06
-0.06%
Nuvalent Inc 주식(NUVL)의 최신 뉴스
FDA Review of Zidesamtinib Data Might Change The Case For Investing In Nuvalent (NUVL) - Yahoo Finance
Cantor Fitzgerald L. P. Makes New $1.95 Million Investment in Nuvalent, Inc. $NUVL - MarketBeat
Does Nuvalent (NUVL) have the potential to rally 37.26% as Wall Street analysts expect? - MSN
Nuvalent to unveil new ROS1+ NSCLC clinical and preclinical data at AACR 2026 - Traders Union
Nuvalent to Present New Preclinical and Clinical Data for Zidesamtinib, an Investigational ROS1-Selective Inhibitor, at AACR Annual Meeting 2026 - PR Newswire
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally - AOL.com
Vestal Point Sells Nuvalent Shares: Portfolio Impact and Company OutlookNews and Statistics - IndexBox
Nuvalent (NUVL) Gets a Buy from Canaccord Genuity - The Globe and Mail
Nuvalent, Inc. (NASDAQ:NUVL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally - The Motley Fool
Nuvalent's Chief Scientific Officer Sells Over 35,000 Shares - TradingView
Nuvalent (NUVL) CSO sells 35,104 shares after major option exercises - Stock Titan
Nuvalent, Inc. Holdings Raised by HighVista Strategies LLC - National Today
Nuvalent, Inc. $NUVL Holdings Raised by HighVista Strategies LLC - MarketBeat
Farallon Capital Management LLC Sells 147,000 Shares of Nuvalent, Inc. $NUVL - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Acurx Pharmaceuticals (ACXP) - The Globe and Mail
Braidwell LP Sells 162,894 Shares of Nuvalent, Inc. - National Today
Cantor Fitzgerald L. P. Acquires Shares of 22,500 Nuvalent, Inc. $NUVL - MarketBeat
Nuvalent, Inc. $NUVL Position Increased by Commodore Capital LP - MarketBeat
Braidwell LP Sells 162,894 Shares of Nuvalent, Inc. $NUVL - MarketBeat
Inflation Data: Is Nuvalent Inc forming a bullish divergence2026 WrapUp & Real-Time Market Trend Scan - baoquankhu1.vn
Is It Time To Reassess Nuvalent (NUVL) After Recent Trial And Pipeline Updates - simplywall.st
Assessing Nuvalent (NUVL) Valuation After Widening Losses And A New US$458.4m Shelf Registration - Yahoo Finance
25,160 Shares in Nuvalent, Inc. $NUVL Acquired by Jefferies Financial Group Inc. - MarketBeat
Canaccord Genuity Initiates Coverage of Nuvalent (NUVL) with Buy Recommendation - MSN
NUVL: Strong clinical data and rapid enrollment position ROS1 and ALK drugs for global launch - TradingView
(NUVL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
American Century Companies Inc. Sells 11,767 Shares of Nuvalent, Inc. $NUVL - MarketBeat
Growth Value: Should I set a stop loss on Nuvalent IncMarket Risk Summary & Real-Time Market Sentiment Reports - baoquankhu1.vn
[144] Nuvalent, Inc. SEC Filing - Stock Titan
Citigroup Inc. Has $3.04 Million Holdings in Nuvalent, Inc. $NUVL - MarketBeat
Aug Sentiment: Will Nuvalent Inc benefit from green energy policiesWeekly Trading Summary & Daily Volume Surge Trade Alerts - baoquankhu1.vn
HC Wainwright Brokers Lift Earnings Estimates for Nuvalent - MarketBeat
Analysts Offer Insights on Healthcare Companies: Quantum-Si (QSI), Moderna (MRNA) and Nuvalent (NUVL) - The Globe and Mail
NUVL: Regulatory filings and commercial launches for ALK and ROS1 NSCLC therapies are on track for 2024 - TradingView
HC Wainwright Brokers Reduce Earnings Estimates for Nuvalent - MarketBeat
NUVLForm S-8Securities to be offered to employees in employee benefit plans - mx.advfn.com
Nuvalent Outlines Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2025 Financial Results - mx.advfn.com
TD Asset Management Inc Increases Position in Nuvalent, Inc. $NUVL - MarketBeat
NUVL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Nuvalent Insider Sold Shares Worth $566,788, According to a Recent SEC Filing - marketscreener.com
Nuvalent Executives Sell Shares Under Trading Plan - TradingView
Nuvalent (NUVL) CDO exercises options and sells 5,500 shares under 10b5-1 plan - Stock Titan
Nuvalent (NUVL) CLO sells 5,500 shares after option exercise - Stock Titan
Assessing Nuvalent (NUVL) Valuation After Recent Share Price Cooling And Strong Multi Year Returns - simplywall.st
Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech With A Promising 40.78% Upside Potential - DirectorsTalk Interviews
UBS Adjusts Price Target on Nuvalent to $138 From $132, Maintains Buy Rating - marketscreener.com
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Atai Beckley N.V. (ATAI) - The Globe and Mail
Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29% - AOL.com
Barclays Sticks to Their Buy Rating for Nuvalent (NUVL) - The Globe and Mail
Does Nuvalent (NUVL) Have the Potential to Rally 37.26% as Wall Street Analysts Expect? - Finviz
Does Nuvalent (NUVL) Have a Chance to Surge by 37.26% According to Wall Street Analysts? - Bitget
Nuvalent (NASDAQ:NUVL) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
Vanguard Group Inc. Raises Holdings in Nuvalent, Inc. $NUVL - MarketBeat
Decoding Nuvalent Inc (NUVL): A Strategic SWOT Insight - GuruFocus
Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug - Investing.com Australia
Nuvalent, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Nuvalent Outlines Recent Pipeline Progress, Reiterates Key Antic - GuruFocus
Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug By Investing.com - Investing.com South Africa
Nuvalent, Inc. SEC 10-K Report - TradingView
Nuvalent (NUVL) targets 2026 launches with ROS1 and ALK lung cancer drugs - Stock Titan
1.20%
0.06%
자본화:
|
볼륨(24시간):